FAM111A regulates replication origin activation and cell fitness.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
12 2023
Historique:
received: 25 04 2023
revised: 19 09 2023
accepted: 19 09 2023
medline: 6 10 2023
pubmed: 5 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

FAM111A is a replisome-associated protein and dominant mutations within its trypsin-like peptidase domain are linked to severe human developmental syndrome, the Kenny-Caffey syndrome. However, FAM111A functions remain unclear. Here, we show that FAM111A facilitates efficient activation of DNA replication origins. Upon hydroxyurea treatment, FAM111A-depleted cells exhibit reduced single-stranded DNA formation and a better survival rate. Unrestrained expression of FAM111A WT and patient mutants causes accumulation of DNA damage and cell death, only when the peptidase domain remains intact. Unrestrained expression of FAM111A WT also causes increased single-stranded DNA formation that relies on S phase entry, FAM111A peptidase activity but not its binding to proliferating cell nuclear antigen. Altogether, these data unveil how FAM111A promotes DNA replication under normal conditions and becomes harmful in a disease context.

Identifiants

pubmed: 37793778
pii: 6/12/e202302111
doi: 10.26508/lsa.202302111
pmc: PMC10551639
pii:
doi:

Substances chimiques

DNA, Single-Stranded 0
Peptide Hydrolases EC 3.4.-
FAM111A protein, human 0
Receptors, Virus 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Cancer Research UK
ID : C57404/A21782
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206293/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00007/15
Pays : United Kingdom

Informations de copyright

© 2023 Rios-Szwed et al.

Références

Curr Opin Cell Biol. 2019 Jun;58:134-141
pubmed: 31200185
Biochimie. 2019 Nov;166:52-76
pubmed: 31505212
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W244-8
pubmed: 15980461
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D187-91
pubmed: 16381842
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Genes Dev. 2007 Dec 15;21(24):3331-41
pubmed: 18079179
Int J Pediatr Endocrinol. 2017;2017:1
pubmed: 28138333
Curr Protoc Cytom. 2001 May;Chapter 8:Unit 8.10
pubmed: 18770738
PLoS Pathog. 2012;8(10):e1002949
pubmed: 23093934
Nat Rev Mol Cell Biol. 2019 Dec;20(12):721-737
pubmed: 31477886
Cancer Res. 2012 Nov 1;72(21):5588-99
pubmed: 23118055
Front Mol Biosci. 2022 Dec 15;9:1081166
pubmed: 36589246
Mol Cancer Ther. 2014 Feb;13(2):433-43
pubmed: 24356813
J Cell Biol. 2014 Jan 6;204(1):29-43
pubmed: 24379417
J Mol Biol. 1999 Sep 17;292(2):195-202
pubmed: 10493868
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
J Mol Biol. 2000 Sep 8;302(1):205-17
pubmed: 10964570
Cancer Sci. 2020 Jul;111(7):2635-2646
pubmed: 32418298
Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13374-13383
pubmed: 31209037
Genes Dev. 2017 Jun 1;31(11):1073-1088
pubmed: 28717046
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W29-37
pubmed: 21593126
Cell. 2013 Nov 21;155(5):1088-103
pubmed: 24267891
EMBO Rep. 2020 Oct 5;21(10):e50662
pubmed: 32776417
Nat Rev Mol Cell Biol. 2017 Oct;18(10):622-636
pubmed: 28811666
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
BMC Bioinformatics. 2005 Apr 27;6:108
pubmed: 15857510
J Bone Miner Res. 2014 Apr;29(4):992-8
pubmed: 23996431
Am J Hum Genet. 2013 Jun 6;92(6):990-5
pubmed: 23684011
RNA. 2019 Nov;25(11):1509-1521
pubmed: 31383795
EMBO J. 2016 Jan 18;35(2):176-92
pubmed: 26620551
BMC Res Notes. 2010 May 26;3(1):146
pubmed: 20504299
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16090-5
pubmed: 20805465
Nature. 2016 Jun 30;534(7609):714-718
pubmed: 27338793
Nat Cell Biol. 2014 Mar;16(3):281-93
pubmed: 24561620
Trends Biochem Sci. 1995 Nov;20(11):478-80
pubmed: 8578593
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
EMBO J. 2023 Sep 18;42(18):e114654
pubmed: 37551430
Mol Cell Biol. 2000 Nov;20(22):8602-12
pubmed: 11046155
Curr Opin Struct Biol. 1996 Jun;6(3):361-5
pubmed: 8804822
Nat Commun. 2020 Mar 12;11(1):1318
pubmed: 32165630
J Virol. 2018 Dec 10;93(1):
pubmed: 30333173
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
EMBO J. 2007 Jun 6;26(11):2719-31
pubmed: 17491592
Nat Protoc. 2019 Jan;14(1):68-85
pubmed: 30464214

Auteurs

Diana O Rios-Szwed (DO)

https://ror.org/03h2bxq36 MCDB, School of Life Sciences, University of Dundee, Dundee, UK.

Vanesa Alvarez (V)

https://ror.org/03h2bxq36 MCDB, School of Life Sciences, University of Dundee, Dundee, UK.

Luis Sanchez-Pulido (L)

https://ror.org/01nrxwf90 MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, Edinburgh, UK.

Elisa Garcia-Wilson (E)

https://ror.org/03h2bxq36 MCDB, School of Life Sciences, University of Dundee, Dundee, UK.

Hao Jiang (H)

https://ror.org/03h2bxq36 MCDB, Quantitative Proteomics Laboratory, School of Life Sciences, University of Dundee, Dundee, UK.

Susanne Bandau (S)

https://ror.org/03h2bxq36 MCDB, School of Life Sciences, University of Dundee, Dundee, UK.

Angus Lamond (A)

https://ror.org/03h2bxq36 MCDB, Quantitative Proteomics Laboratory, School of Life Sciences, University of Dundee, Dundee, UK.

Constance Alabert (C)

https://ror.org/03h2bxq36 MCDB, School of Life Sciences, University of Dundee, Dundee, UK c.alabert@dundee.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH